Back to all lessons
Awareness Lessons
2 months ago

Czech Court Rules Random Identifiers in Health Data Constitute Pseudonymization, Not Anonymization

The Supreme Administrative Court of the Czech Republic clarified a critical distinction under GDPR: adding a random identifier to health datasets does not constitute true anonymization if a third party can use it to re-link records and identify individuals. The court recognized that modern technical capabilities and publicly available information make re-identification feasible, meaning such data retains its 'personal data' status under GDPR. This ruling matters because organizations cannot rely on superficial obfuscation techniques to escape GDPR obligations — genuine anonymization must be irreversible under realistic adversarial conditions. Healthcare and data analytics organizations must rigorously assess re-identification risk before treating any dataset as anonymous and outside the scope of data protection law.

Tactical Insight

Immediate actions

  • Conduct a formal re-identification risk assessment on all datasets currently classified as 'anonymous' to verify they meet the GDPR standard.
  • Engage a qualified data protection expert or DPO to review any pseudonymization techniques in use against current technical attack capabilities.

Data governance improvements

  • Implement a documented anonymization policy that distinguishes clearly between anonymization and pseudonymization, specifying which GDPR obligations apply to each.
  • Apply privacy-enhancing technologies (e.g., differential privacy, k-anonymity, data aggregation) when sharing health datasets with third parties to reduce re-identification risk.
  • Maintain a data processing register that records the legal basis and anonymization method for every health dataset shared externally.

Monitoring & compliance measures

  • Establish a periodic review process to re-evaluate anonymization techniques as new re-identification methods and public datasets emerge.
  • Ensure data sharing agreements with healthcare consultancies explicitly prohibit re-identification attempts and define enforceable consequences for violations.